1. National Survey of Canadian Neurologists’ Current Practice for Transient Ischemic Attack and the Need for a Clinical Decision Rule
- Author
-
Cheryl Symington, Monica Taljaard, Jamie C. Brehaut, Ian G. Stiell, Jeffrey J. Perry, Marlène Mansour, and Michael Sharma
- Subjects
Adult ,Male ,Canada ,medicine.medical_specialty ,Neurology ,MEDLINE ,Risk Factors ,Physicians ,medicine ,Humans ,Disease management (health) ,Clinical decision ,Stroke ,Aged ,Advanced and Specialized Nursing ,Response rate (survey) ,business.industry ,Data Collection ,Disease Management ,Decision rule ,Middle Aged ,medicine.disease ,Ischemic Attack, Transient ,Current practice ,Family medicine ,Female ,Neurology (clinical) ,Medical emergency ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and Purpose— Four percent to 10% of patients with transient ischemic attack (TIA) have a stroke or die within 1 week of their diagnosis. This national survey examined Canadian neurologists’ current practice for managing TIA, the need for a clinical decision rule to identify high-risk patients, and the required sensitivity of such a rule. Methods— We surveyed 650 neurologists registered in a national physician directory. We used a modified Dillman technique with a prenotification letter and up to 5 survey attempts using a mailed letter. Neurologists were asked 33 questions about demographics, current management of adult patients with TIA, if a clinical decision rule is required to identify high-risk patients with TIA for impending stroke/death, and the required sensitivity of this rule. Results— We had a response rate of 49.8% (324 of 650). Respondents were 78.3% male and had a mean age of 50.3 years. Of respondents, 49.2% (95% CI: 45.3% to 53.1%) reported using an existing clinical tool to risk-stratify patients. Overall, 95.0% (95% CI: 93.3% to 96.7%) reported they would consider using a sensitive, validated clinical decision rule for risk-stratifying patients with TIA. The median required sensitivity of a rule was 92% (interquartile range, 90 to 95). Conclusions— We found that Canadian neurologists would use a highly sensitive clinical decision rule to risk-stratify patients with TIA. The median required sensitivity of 92% is higher than the high risk category of any existing tool. Our results indicate a clinical decision rule to predict high-risk TIA needs to be more sensitive than the currently available rules.
- Published
- 2010